Natural Killer Cells Are Characterized by the Concomitantly Increased Interferon-γ and Cytotoxicity in Acute Resolved Hepatitis B Patients

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Zhao, Juanjuan ^a   Li, Yonggang ^b   Jin, Lei ^b   Zhang, Shuye ^b   Fan, Rong ^b   Sun, Yanling ^b   Zhou, Chunbao ^b   Shang, Qinghua ^c   Li, Wengang ^b   Zhang, Zheng ^b   Wang, Fu Sheng ^a,b  

^a INSTITUTE OF BIOPHYSICS   (China)

^b BEIJING 302 HOSPITAL   (China)

^c Department of Liver Disease   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; CD158B ANTIGEN; CD3 ANTIGEN; CD38 ANTIGEN; CD56 ANTIGEN; CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HLA DR ANTIGEN; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL1; LYMPHOCYTE ANTIGEN; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 2; NATURAL KILLER CELL RECEPTOR NKG2D; RANTES; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG; UNINDEXED DRUG; VIRUS DNA;

ADOLESCENT; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIGEN EXPRESSION; ARTICLE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; CONVALESCENCE; CYTOKINE PRODUCTION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS VIRUS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INFECTION CONTROL; LIVER INJURY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBPOPULATION; MALE; MOLECULAR PATHOLOGY; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; PROTEIN FUNCTION; UPREGULATION; VIRAL CLEARANCE; VIRUS LOAD;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ANTIGENS, CD56; DNA, VIRAL; FEMALE; FLOW CYTOMETRY; HEPATITIS B; HEPATITIS B, CHRONIC; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTERFERON-GAMMA; KILLER CELLS, NATURAL; LIVER; MALE; MIDDLE AGED;

HEPATITIS B VIRUS;

EID: 84868324382     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049135     Document Type: Article

References (37)

1. Rehermann B, Nascimbeni M, (2005) Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 5: 215-229.
2. Zhang Z, Zhang JY, Wang LF, Wang FS, (2012) Immunopathogenesis and prognostic immune markers of chronic hepatitis B virus infection. J Gastroenterol Hepatol 27: 223-230.
3. Wang FS, Zhang Z, (2009) Host immunity influences disease progression and antiviral efficacy in humans infected with hepatitis B virus. Expert Rev Gastroenterol Hepatol 3: 499-512.
4. Thimme R, Wieland S, Steiger C, Ghrayeb J, Reimann KA, et al. (2003) CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. J Virol 77: 68-76.
5. Boettler T, Panther E, Bengsch B, Nazarova N, Spangenberg HC, et al. (2006) Expression of the interleukin-7 receptor alpha chain (CD127) on virus-specific CD8+ T cells identifies functionally and phenotypically defined memory T cells during acute resolving hepatitis B virus infection. J Virol 80: 3532-3540.
6. Urbani S, Boni C, Missale G, Elia G, Cavallo C, et al. (2002) Virus-specific CD8+ lymphocytes share the same effector-memory phenotype but exhibit functional differences in acute hepatitis B and C. J Virol. 76: 12423-12434.
7. Webster GJ, Reignat S, Maini MK, Whalley SA, Ogg GS, et al. (2000) Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms. Hepatology 32: 1117-1124.
8. Chang JJ, Thompson AJ, Visvanathan K, Kent SJ, Cameron PU, et al. (2007) The phenotype of hepatitis B virus-specific T cells differ in the liver and blood in chronic hepatitis B virus infection. Hepatology 46: 1332-1340.
9. Boni C, Fisicaro P, Valdatta C, Amadei B, Di Vincenzo P, et al. (2007) Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection. J Virol 81: 4215-4225.
10. Lopes AR, Kellam P, Das A, Dunn C, Kwan A, et al. (2008) Bim-mediated deletion of antigen-specific CD8 T cells in patients unable to control HBV infection. J Clin Invest 118: 1835-1845.
11. Das A, Hoare M, Davies N, Lopes AR, Dunn C, et al. (2008) Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection. J Exp Med 205: 2111-2124.
12. Das A, Maini MK, (2010) Innate and adaptive immune responses in hepatitis B virus infection. Dig Dis 28: 126-132.
13. Racanelli V, Rehermann B, (2006) The liver as an immunological organ. Hepatology 43: S54-62.
14. Gao B, Jeong WI, Tian Z, (2008) Liver: An organ with predominant innate immunity. Hepatology 47: 729-736.
15. Lanier LL, (2005) NK cell recognition. Annu Rev Immunol 23: 225-274.
16. Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S, (2008) Functions of natural killer cells. Nat Immunol 9: 503-510.
17. Ahlenstiel G, Titerence RH, Koh C, Edlich B, Feld JJ, et al. (2010) Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner. Gastroenterology 138: 325-335 e321-322.
18. Oliviero B, Varchetta S, Paudice E, Michelone G, Zaramella M, et al. (2009) Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections. Gastroenterology 137: 1151-1160, 1160 e1151-1157.
19. Bonorino P, Ramzan M, Camous X, Dufeu-Duchesne T, Thelu MA, et al. (2009) Fine characterization of intrahepatic NK cells expressing natural killer receptors in chronic hepatitis B and C. J Hepatol. 51: 458-467.
20. Zhang Z, Zhang S, Zou Z, Shi J, Zhao J, et al. (2011) Hypercytolytic activity of hepatic natural killer cells correlates with liver injury in chronic hepatitis B patients. Hepatology 53: 73-85.
21. Dunn C, Brunetto M, Reynolds G, Christophides T, Kennedy PT, et al. (2007) Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage. J Exp Med 204: 667-680.
22. Fisicaro P, Valdatta C, Boni C, Massari M, Mori C, et al. (2009) Early kinetics of innate and adaptive immune responses during hepatitis B virus infection. Gut 58: 974-982.
23. Dunn C, Peppa D, Khanna P, Nebbia G, Jones M, et al. (2009) Temporal analysis of early immune responses in patients with acute hepatitis B virus infection. Gastroenterology 137: 1289-1300.
24. Yang PL, Althage A, Chung J, Maier H, Wieland S, et al. (2010) Immune effectors required for hepatitis B virus clearance. Proc Natl Acad Sci U S A 107: 798-802.
25. Stacey AR, Norris PJ, Qin L, Haygreen EA, Taylor E, et al. (2009) Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections. J Virol 83: 3719-3733.
26. Golden-Mason L, Stone AE, Bambha KM, Cheng L, Rosen HR (2012) Race- and genderrelated variation in NKp46 expression associated with differential anti-HCV immunity. Hepatology doi: 10.1002/hep.25771.
27. Kramer B, Korner C, Kebschull M, Glassner A, Eisenhardt M, et al. (2012) NKp46(High) expression defines a NK cell subset that is potentially involved in control of HCV replication and modulation of liver fibrosis. Hepatology doi: 10.1002/hep.25804.
28. Heeg M, Thimme R (2012) NK cells and hepatitis C; NKp46 expression linked to antiviral and antifibrotic activity. Hepatology.
29. Mondelli MU, Varchetta S, Oliviero B, (2010) Natural killer cells in viral hepatitis: facts and controversies. Eur J Clin Invest 40: 851-863.
30. Edlich B, Ahlenstiel G, Azpiroz AZ, Stoltzfus J, Noureddin M, et al. (2012) Early changes in interferon signaling define natural killer cell response and refractoriness to interferon-based therapy of hepatitis C patients. Hepatology 55: 39-48.
31. Sprengers D, van der Molen RG, Kusters JG, De Man RA, Niesters HG, et al. (2006) Analysis of intrahepatic HBV-specific cytotoxic T-cells during and after acute HBV infection in humans. J Hepatol 45: 182-189.
32. Gujar SA, Jenkins AK, Guy CS, Wang J, Michalak TI, (2008) Aberrant lymphocyte activation precedes delayed virus-specific T-cell response after both primary infection and secondary exposure to hepadnavirus in the woodchuck model of hepatitis B virus infection. J Virol 82: 6992-7008.
33. Bertoletti A, Ferrari C, (2003) Kinetics of the immune response during HBV and HCV infection. Hepatology 38: 4-13.
34. Guy CS, Mulrooney-Cousins PM, Churchill ND, Michalak TI, (2008) Intrahepatic expression of genes affiliated with innate and adaptive immune responses immediately after invasion and during acute infection with woodchuck hepadnavirus. J Virol 82: 8579-8591.
35. Zhang Z, Zhang JY, Wherry EJ, Jin B, Xu B, et al. (2008) Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B. Gastroenterology 134: 1938-1949, 1949 e1931-1933.
36. Guidotti LG, Rochford R, Chung J, Shapiro M, Purcell R, et al. (1999) Viral clearance without destruction of infected cells during acute HBV infection. Science 284: 825-829.
37. Cai L, Zhang Z, Zhou L, Wang H, Fu J, et al. (2008) Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients. Clin Immunol 129: 428-437.